Molecular Biology of Cannabinoid Receptors 107Bouaboula M, Desnoyer N, Carayon P, Combes T, Casellas P (1999a) Gi protein modu-
lation induced by a selective inverse agonist for the peripheral cannabinoid receptor
CB2: implication for intracellular signalization cross-regulation. Mol Pharmacol 55:473–
480
Bouaboula M, Dussossoy D, Casellas P (1999b) Regulation of peripheral cannabinoid re-
ceptor CB2 phosphorylation by the inverse agonist SR 144528. Implications for receptor
biological responses. J Biol Chem 274:20397–20405
Breivogel C, Childers S, Deadwyler S, Hampson R, Vogt L, Sim-Selley L (1999) Chronic
delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid
receptors and cannabinoid receptor-activated G proteins in rat brain. J Neurochem
73:2447–2459
Breivogel CS, Griffin G, Di Marzo V, Martin BR (2001) Evidence for a new G protein-coupled
cannabinoid receptor in mouse brain. Mol Pharmacol 60:155–163
Brown SM, Wager-Miller J, Mackie K (2002) Cloning and molecular characterization of the
rat CB2 cannabinoid receptor. Biochim Biophys Acta 1576:255–264
Buckley NE, McCoy KL, Mezey E, Bonner T, Zimmer A, Felder CC, Glass M (2000) Im-
munomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2)
receptor. Eur J Pharmacol 396:141–149
Burley S, Petsko G (1985) Aromatic-aromatic interaction: a mechanism of protein structure
stabilization. Science 229:23–28
CaenazzoL,HoeheM,HsiehW,BerrettiniW,BonnerT,GershonE(1991)HindIIIidentifiesa
two allele DNA polymorphism of the human cannabinoid receptor gene (CNR). Nucleic
Acids Res 19:4798
Chakrabarti A, Onaivi ES, Chaudhuri G (1995) Cloning and sequencing of a cDNA encoding
the mouse brain-type cannabinoid receptor protein. DNA Seq 5:385–388
Chen J, Paredes W, Li J, Smith D, Lowinson J, Gardner E (1990) Ð9-Tetrahydrocannabinol
produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in
nucleus accumbens of conscious, freely-moving rats as measured by intracerebral mi-
crodialysis. Psychopharmacology (Berl) 102:156–162
Chen J, Paredes W, Lowinson J, Gardner E (1991) Strain-specific facilitation of dopamine
efflux by delta 9-tetrahydrocannabinol in the nucleus accumbens of rat: an in vivo
microdialysis study. Neurosci Lett 129:136–180
Chin C, Abadji V, Lucas-Lenard J, Kendall D (1998) Ligand binding and modulation of cyclic
AMP levels depends on the chemical nature of residue 192 of the human cannabinoid
receptor 1. J Neurochem 70:366–373
Chin C, Murphy J, Huffman J, Kendall D (1999) The third transmembrane helix of the
cannabinoid receptor plays a role in the selectivity of aminoalkylindoles for CB2, pe-
ripheral cannabinoid receptor. J Pharmacol Exp Ther 291:837–844
Comings D, Muhleman D, Gade R, Johnson P, Verde R, Saucier G, MacMurray J (1997)
Cannabinoid receptor gene (CNR1): association with i.v. drug use. Mol Psychiatry
2:161–168
Cottone E, Salio C, Conrath M, Franzoni MF (2003) Xenopus laevis CB1 cannabinoid
receptor: molecular cloning and mRNA distribution in the central nervous system.
J Comp Neurol 464:487–496
Coutts A, Brewster N, Ingram T, Razdan R, Pertwee R (2000) Comparison of novel cannabi-
noid partial agonists and SR141716A in the guinea-pig small intestine. Br J Pharmacol
129:645–652
DeVriesTJ,ShahamY,HombergJR,CrombagH,SchuurmanK,DiebenJ,Vanderschuren
LJ, Schoffelmeer AN (2001) A cannabinoid mechanism in relapse to cocaine seeking.
Nat Med 7:1151–1154
Deutsch DG, Chin SA (1993) Enzymatic synthesis and degradation of anandamide, a
cannabinoid receptor agonist. Biochem Pharmacol 46:791–796
DevaneWA,HanusL,BreuerA,PertweeRG,StevensonLA,GriffinG,GibsonD,Mandelbaum
A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that
binds to the cannabinoid receptor. Science 258:1946–1949